Overview
Prostate cancer imaging
Focal therapy of prostate cancer
Prostate cancer outcomes
Kidney cancer outcomes
Minimally invasive surgery
Nerve sparing cryotherapy
Robotic surgery
Focal therapy of prostate cancer
Prostate cancer outcomes
Kidney cancer outcomes
Minimally invasive surgery
Nerve sparing cryotherapy
Robotic surgery
Current Appointments & Affiliations
Lawrence C. Katz Distinguished Professor
·
2024 - Present
Urology,
Clinical Science Departments
Professor of Urology
·
2011 - Present
Urology,
Clinical Science Departments
Professor in Radiology
·
2023 - Present
Radiology,
Clinical Science Departments
Member of the Duke Cancer Institute
·
1998 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Irreversible Electroporation for Prostate Tissue Ablation in Patients with Intermediate-risk Prostate Cancer: Results from the PRESERVE Trial.
Journal Article Eur Urol · January 2026 BACKGROUND AND OBJECTIVE: The PRESERVE study (NCT04972097) assessed the safety and effectiveness of irreversible electroporation (IRE) with the NanoKnife System to ablate prostate tissue in patients with intermediate-risk prostate cancer (PCa). METHODS: Th ... Full text Link to item CiteExternal validation of inter-reader reliability of the Prostate Imaging after Focal Ablation (PI-FAB) scoring system following focal cryoablation and focal high-intensity focused ultrasound.
Journal Article Eur Radiol · November 2025 OBJECTIVES: The efficacy of focal therapy (FT) has improved with the use of multiparametric MRI (mpMRI) for lesion identification, though standardized mpMRI reporting post-FT is lacking. The Prostate Imaging after Focal Ablation (PI-FAB) scoring system was ... Full text Link to item CiteTranscriptomic predictors of prostate cancer recurrence following focal cryotherapy: a pooled analysis of phase II trial and prospective cohort data.
Journal Article J Natl Cancer Cent · October 2025 OBJECTIVE: Focal therapy (FT) is a potential treatment option for limited-volume clinically-significant prostate cancer (csPCa). However, despite rigorous selection, approximately 20% of patients experience early failure. We investigated the association of ... Full text Link to item CiteRecent Grants
Hessian Map- Platelet Proteomic Assay
Clinical TrialPrincipal Investigator · Awarded by Hessian Labs, Inc. · 2025 - 2030Evaluation of a Soft Tissue Biopsy System for Trans-Rectal and Trans-Perineal Biopsy of the Prostate
Clinical TrialPrincipal Investigator · Awarded by URO-1 Inc. · 2023 - 2028VAPOR 2 Study
Clinical TrialPrincipal Investigator · Awarded by Francis Medical, Inc. · 2023 - 2028View All Grants
Education, Training & Certifications
The University of Chicago ·
1991
M.D.